DELIVEREX - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79282940
Serial Number
79282940
Registration Number
6405652
Word Mark
DELIVEREX
Status
700 - Registered
Status Date
2021-07-06
Filing Date
2020-01-31
Registration Number
6405652
Registration Date
2021-07-06
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2021-04-20
Attorney Name
Law Office Assigned Location Code
O10
Employee Name
PAYABYAB, EDWARD TAN
Statements
Goods and Services
Pharmaceutical preparations and substances for the treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies in the nature of mitochondrial disease, joint strain and tears, ligament strain and tears, muscle atrophy, muscular dystrophy, neuromuscular diseases, neurological disorders, neurodegenerative disorders, inflammatory disorders, infectious diseases, genetic diseases, rare diseases, in-born errors of metabolism, lysosomal storage disorders and urea cycle disorders; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered and purified exosomes in the form of a liquid solution and lyophilised preparation for therapeutic use in the nature of treatment of for the treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies in the nature of mitochondrial disease, joint strain and tears, ligament strain and tears, muscle atrophy, muscular dystrophy, neuromuscular diseases, neurological disorders, neurodegenerative disorders, inflammatory disorders, infectious diseases, genetic diseases, rare diseases, in-born errors of metabolism, lysosomal storage disorders and urea cycle disorders; pharmaceutical preparations, namely, exosomes to deliver protein for genetic therapy; Medicine for treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies in the nature of mitochondrial disease, joint strain and tears, ligament strain and tears, muscle atrophy, muscular dystrophy, neuromuscular diseases, neurological disorders, neurodegenerative disorders, inflammatory disorders, infectious diseases, genetic diseases, rare diseases, in-born errors of metabolism, lysosomal storage disorders and urea cycle disorders; biological preparations for the treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies such as mitochondrial disease, joint and ligament strains and tears, muscle atrophy, muscular dystrophy; mixed biological preparations for the prevention and treatment of infectious diseases; EV-based nucleic acid therapeutics in the nature of pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the prevention and treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies in the nature of mitochondrial disease, joint strain and tears, ligament strain and tears, muscle atrophy, muscular dystrophy, neuromuscular diseases, neurological disorders, neurodegenerative disorders, inflammatory disorders, infectious diseases, genetic diseases, rare diseases, in-born errors of metabolism, lysosomal storage disorders and urea cycle disorders; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies in the nature of mitochondrial disease, joint strains and tears, ligament strains and tears, muscle atrophy, and muscular dystrophy
Goods and Services
Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; biological research; clinical research in the field of transformational therapeutics for medicine, gene therapy, protein replacement therapy, and nucleic acid therapy; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science
Goods and Services
Medical services; medical and pharmaceutical consultancy; medical services relating to the diagnosis and treatment of persons; medical analysis service relating to the diagnosis and treatment of persons provided by medical laboratories; medical analysis and examinations for the diagnosis of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies in the nature of mitochondrial disease, joint strain and tears, ligament strain and tears, muscle atrophy, muscular dystrophy, neuromuscular diseases, neurological disorders, neurodegenerative disorders, inflammatory disorders, infectious diseases, rare diseases, genetic diseases, in-born errors of metabolism, lysosomal storage disorders and urea cycle disorders; medical treatment services in the field of biotherapeutics for the treatment of infectious diseases, cancer, neurological disorders, neurodegenerative disorders, inflammatory disorders, rare diseases, genetic and metabolic disorders; medical screening; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of viral and bacterial based infections and diseases; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies in the nature of mitochondrial disease, joint and ligament strains and tears, muscle atrophy, muscular dystrophy
Pseudo Mark
DELIVER EX
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-04-13
Primary Code
005
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-04-13
Primary Code
044
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Bryce J. Maynard
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1524524
International Registration Date
2020-01-31
International Publication Date
2020-04-09
International Renewal Date
2030-01-31
Auto Protection Date
2021-10-09
International Status
001 - Request for extension of protection established
International Status Date
2020-04-09
Priority Claimed In
True
Priority Claimed Date
2019-11-05
First Refusal In
True
Trademark Events
Event DateEvent Description
2020-04-09SN ASSIGNED FOR SECT 66A APPL FROM IB
2020-04-13NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-04-17APPLICATION FILING RECEIPT MAILED
2020-04-20ASSIGNED TO EXAMINER
2020-04-29NON-FINAL ACTION WRITTEN
2020-04-30NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2020-05-14REFUSAL PROCESSED BY MPU
2020-05-14NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2020-05-29REFUSAL PROCESSED BY IB
2020-07-30NEW REPRESENTATIVE AT IB RECEIVED
2020-10-16TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-01-27ASSIGNED TO LIE
2021-01-28CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-01-28TEAS/EMAIL CORRESPONDENCE ENTERED
2021-03-06SUSPENSION LETTER WRITTEN
2021-03-06LETTER OF SUSPENSION E-MAILED
2021-03-06NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2021-03-13EXAMINERS AMENDMENT -WRITTEN
2021-03-13EXAMINERS AMENDMENT E-MAILED
2021-03-13NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2021-03-13EXAMINER'S AMENDMENT ENTERED
2021-03-13APPROVED FOR PUB - PRINCIPAL REGISTER
2021-03-31NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-03-31NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2021-03-31NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2021-04-18NOTIFICATION PROCESSED BY IB
2021-04-20PUBLISHED FOR OPPOSITION
2021-04-20OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-05-01LIMITATION OF GOODS RECEIVED FROM IB
2021-05-04LIMITATION FROM THE IB EXAMINED AND ENTERED
2021-07-06REGISTERED-PRINCIPAL REGISTER
2021-10-06FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2021-11-01FINAL DISPOSITION PROCESSED
2021-11-01FINAL DISPOSITION NOTICE SENT TO IB
2021-11-23FINAL DECISION TRANSACTION PROCESSED BY IB
2021-12-04NEW REPRESENTATIVE AT IB RECEIVED